ホーム › 卵巣がん › ケンタッキー州 › Lexington
Lexington、KYにおける卵巣がんの臨床試験
Lexingtonとその周辺地域（約30マイル以内）の拠点で、卵巣がんに関する16件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
被験者募集中第2/3相
- University of Kentucky/Markey Cancer Center, Lexington
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
被験者募集中第2相
- CommonSpirit Saint Joseph Medical Center - East Lexington, Lexington
- University of Kentucky/Markey Cancer Center, Lexington
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
被験者募集中第2相
- Baptist Health Lexington /ID# 275218, Lexington
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
被験者募集中第3相
- Baptist Health Lexington, Lexington
A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
被験者募集中第2相
- Baptist Health Lexington /ID# 278267, Lexington
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
被験者募集中
- Baptist Health Lexington, Lexington
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
被験者募集中第3相
- Baptist Health Lexington, Lexington
- CommonSpirit Saint Joseph Hospital - Lexington, Lexington
- Saint Joseph Radiation Oncology Resource Center, Lexington
- 他1件
Lead-212 PSV359 Therapy for Patients With Solid Tumors
被験者募集中第1/2相
- University of Kentucky, Lexington
EXoPERT EMERALD Clinical Study
被験者募集中観察研究健康なボランティア歓迎
- Lexington VA Healthcare System, Lexington
A Study to Assess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression Treated With Intravenously (IV) Infused Mirvetuximab Soravtansine
被験者募集中第2相
- Baptist Health Lexington /ID# 272211, Lexington
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
被験者募集中第3相
- University of Kentucky Medical Center, Lexington
Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC
被験者募集中第2相
- University of Kentucky, Lexington
First in Human Study of TORL-1-23 in Participants With Advanced Cancer
被験者募集中第1相
- University of Kentucky Medical Center, Lexington
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
被験者募集中第1相
- University of Kentucky Markey Cancer Center, Lexington
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
被験者募集中観察研究健康なボランティア歓迎
- Baptist Lexington, Lexington
Transvaginal Ultrasonography as a Screening Method for Ovarian Cancer
被験者募集中健康なボランティア歓迎
- Markey Cancer Center, Lexington
他の都市における卵巣がんの試験
- Houston, TX89件の研究
- New York City, NY69件の研究
- Boston, MA61件の研究
- Los Angeles, CA50件の研究
- Nashville, TN49件の研究
- Arlington, VA46件の研究
- Philadelphia, PA44件の研究
- Columbus, OH39件の研究
- St. Louis, MO38件の研究
- Chicago, IL36件の研究
- San Antonio, TX31件の研究
- Cleveland, OH30件の研究
Lexingtonにおける他の研究
- 非小細胞肺癌23件の研究
- 肺がん18件の研究
- 前立腺がん14件の研究
- がん（全種類）14件の研究
- 乳がん14件の研究
- 転移性癌11件の研究
- 大腸癌11件の研究
- 心不全11件の研究
- 悪性黒色腫10件の研究
- 急性骨髄性白血病10件の研究
- 肥満症10件の研究
- 頭頸部扁平上皮癌9件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。